Cue Biopharma Inc (CUE)
1.07
+0.04
(+3.88%)
USD |
NASDAQ |
Nov 22, 12:11
Cue Biopharma Price to Book Value: 2.672 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 21, 2024 | 2.572 |
November 20, 2024 | 2.722 |
November 19, 2024 | 2.697 |
November 18, 2024 | 2.747 |
November 15, 2024 | 3.109 |
November 14, 2024 | 3.746 |
November 13, 2024 | 3.746 |
November 12, 2024 | 4.246 |
November 11, 2024 | 4.439 |
November 08, 2024 | 4.082 |
November 07, 2024 | 4.225 |
November 06, 2024 | 3.916 |
November 05, 2024 | 4.059 |
November 04, 2024 | 3.537 |
November 01, 2024 | 3.608 |
October 31, 2024 | 3.821 |
October 30, 2024 | 4.154 |
October 29, 2024 | 4.011 |
October 28, 2024 | 4.225 |
October 25, 2024 | 3.513 |
October 24, 2024 | 3.703 |
October 23, 2024 | 3.726 |
October 22, 2024 | 3.798 |
October 21, 2024 | 3.988 |
October 18, 2024 | 2.872 |
Date | Value |
---|---|
October 17, 2024 | 2.635 |
October 16, 2024 | 2.540 |
October 15, 2024 | 2.658 |
October 14, 2024 | 2.872 |
October 11, 2024 | 2.920 |
October 10, 2024 | 3.157 |
October 09, 2024 | 2.860 |
October 08, 2024 | 2.920 |
October 07, 2024 | 3.287 |
October 04, 2024 | 2.753 |
October 03, 2024 | 1.944 |
October 02, 2024 | 1.741 |
October 01, 2024 | 1.708 |
September 30, 2024 | 1.797 |
September 27, 2024 | 1.528 |
September 26, 2024 | 1.022 |
September 25, 2024 | 1.069 |
September 24, 2024 | 1.090 |
September 23, 2024 | 1.078 |
September 20, 2024 | 1.179 |
September 19, 2024 | 1.271 |
September 18, 2024 | 1.246 |
September 17, 2024 | 1.282 |
September 16, 2024 | 1.268 |
September 13, 2024 | 1.325 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.022
Minimum
Sep 26 2024
19.33
Maximum
Jun 02 2020
4.574
Average
3.401
Median
Aug 07 2023
Price to Book Value Benchmarks
Biomarin Pharmaceutical Inc | 2.265 |
Arbutus Biopharma Corp | 6.214 |
GlycoMimetics Inc | 1.804 |
FibroGen Inc | -- |
Cidara Therapeutics Inc | 1.249 |
Price to Book Value Related Metrics
PS Ratio | 5.558 |
Price | 1.07 |
Earnings Yield | -85.05% |
Market Cap | 67.78M |